ChemAesthetic | For research use only
βΈ»
π¬ Compound Overview
Retatrutide is a triple-agonist research compound, studied for its interaction with GLP-1, GIP, and glucagon receptors.
It is under active investigation in models related to energy regulation, appetite modulation, and body composition pathways.
βΈ»
π§ Reconstitution Instructions
Mix using sterile bacteriostatic water.
Gently swirl after adding β do not shake.
(Insert mixing guide table here)
π Dosing Guidelines (For Research Use Only)
β’ Standard reference dosing: 1β2mg per week
β’ Increase gradually in 1β2mg increments as required
β’ Can be administered once weekly or split across multiple days
β’ Wipe vial stopper with alcohol swab before each draw
Mix using sterile bacteriostatic water.
Gently swirl after adding β do not shake.
| Vial Strength | Bac Water Volume | Resulting Concentration |
|---|---|---|
| 10mg vial | 1ml (100 units) | 1mg per 10 units |
| 20mg vial | 2ml (200 units) | 1mg per 10 units |
| 30mg vial | 3ml (300 units) | 1mg per 10 units |
| 50mg vial | 2.5ml (250 units) | 2mg per 10 units |
Use an insulin syringe (100-unit scale) for accurate measuring.
βΈ»
π§ Storage
β’ Store mixed solution refrigerated (2β8Β°C)
β’ Discard reconstituted solution after 60 days
βΈ»
π Legal & Research Notice
β’ This protocol is for laboratory research use only
β’ Not approved for human or veterinary applications
β’ Distributed exclusively by ChemAesthetic for authorized research professionals
π Research Protocol Pages
Select a compound to view detailed protocol and study information: